Author
Lindsay J. Caverly
Also Known As
L. Caverly, L.J. Caverly, Lindsay Caverly, Lindsay J Caverly, Lindsay J. Caverly, Lindsay J. Caverly (692044)
71
Publications
1.2K
Citations
20
H-Index
26
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 10 | 10 | 452 |
2 | Microbiology | 7 | 7 | 315 |
3 | Pathology | 3 | 3 | 142 |
4 | Pulmonary Disease | 3 | 3 | 117 |
5 | Immunology | 2 | 2 | 115 |
Lindsay J. Caverly
×
23
Publications
739
Citations
15
H-Index
| Year | Citations | |
|---|---|---|
Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell, | 2022 | 116 |
2018 | 94 | |
2013 | 66 | |
2015 | 49 | |
2013 | 46 | |
2010 | 39 | |
2016 | 37 | |
2019 | 35 | |
2020 | 34 | |
2019 | 33 |
Page 1
Page 1